Thomasville National Bank Abb Vie Inc. Transaction History

Thomasville National Bank

$1.3 Billion
Q3 2024

A detailed history of Thomasville National Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Thomasville National Bank holds 30,142 shares of ABBV stock, worth $5.43 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

30,142

Previous 30,918 2.51%

Holding current value

$5.43 Million

Previous $5.3 Million 12.24%

% of portfolio

0.46%

Previous 0.44%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$163.84 - $199.33 $127,139 - $154,680	-776 Reduced 2.51%	30,142 $5.95 Million
Q2 2024 Jul 10, 2024	SELL	$154.79 - $180.76 $23,992 - $28,017	-155 Reduced 0.5%	30,918 $5.3 Million
Q1 2024 Apr 10, 2024	SELL	$159.82 - $182.1 $32,283 - $36,784	-202 Reduced 0.65%	31,073 $5.66 Million
Q4 2023 Jan 11, 2024	SELL	$137.6 - $154.97 $118,336 - $133,274	-860 Reduced 2.68%	31,275 $4.85 Million
Q3 2023 Oct 10, 2023	BUY	$133.59 - $154.65 $21,507 - $24,898	161 Added 0.5%	32,135 $4.79 Million
Q2 2023 Jul 10, 2023	SELL	$132.51 - $164.9 $21,599 - $26,878	-163 Reduced 0.51%	31,974 $4.31 Million
Q1 2023 Apr 10, 2023	SELL	$144.61 - $166.54 $71,581 - $82,437	-495 Reduced 1.52%	32,137 $5.12 Million
Q4 2022 Jan 10, 2023	SELL	$138.31 - $165.87 $21,161 - $25,378	-153 Reduced 0.47%	32,632 $5.27 Million
Q3 2022 Oct 03, 2022	SELL	$134.21 - $153.93 $260,770 - $299,085	-1,943 Reduced 5.59%	32,785 $4.4 Million
Q2 2022 Jul 28, 2022	SELL	$137.62 - $174.96 $2.58 Million - $3.28 Million	-18,756 Reduced 35.07%	34,728 $5.32 Million
Q1 2022 Apr 14, 2022	SELL	$131.98 - $163.75 $15.1 Million - $18.8 Million	-114,540 Reduced 68.17%	53,484 $8.67 Million
Q4 2021 Jan 18, 2022	BUY	$107.43 - $135.93 $18,370 - $23,244	171 Added 0.1%	168,024 $22.8 Million
Q3 2021 Oct 04, 2021	BUY	$106.4 - $120.78 $120,551 - $136,843	1,133 Added 0.68%	167,853 $18.1 Million
Q2 2021 Jul 02, 2021	SELL	$105.21 - $117.21 $552,562 - $615,586	-5,252 Reduced 3.05%	166,720 $18.8 Million
Q1 2021 Apr 01, 2021	BUY	$102.3 - $112.62 $1.12 Million - $1.23 Million	10,903 Added 6.77%	171,972 $13.1 Million
Q4 2020 Jan 04, 2021	SELL	$80.49 - $108.67 $27,930 - $37,708	-347 Reduced 0.21%	161,069 $17.3 Million
Q3 2020 Oct 01, 2020	SELL	$85.91 - $100.83 $639,428 - $750,477	-7,443 Reduced 4.41%	161,416 $14.1 Million
Q2 2020 Jul 01, 2020	SELL	$73.37 - $98.18 $11,812 - $15,806	-161 Reduced 0.1%	168,859 $16.6 Million
Q1 2020 Apr 02, 2020	SELL	$64.5 - $97.79 $32,959 - $49,970	-511 Reduced 0.3%	169,020 $12.9 Million
Q4 2019 Jan 07, 2020	BUY	$72.13 - $90.25 $36,858 - $46,117	511 Added 0.3%	169,531 $15 Million
Q3 2019 Oct 02, 2019	BUY	$62.98 - $75.72 $7.81 Million - $9.39 Million	124,007 Added 275.49%	169,020 $12.8 Million
Q2 2019 Jul 01, 2019	BUY	$65.7 - $83.98 $73,452 - $93,889	1,118 Added 2.55%	45,013 $3.27 Million
Q1 2019 May 16, 2019	BUY	$77.14 - $90.79 $149,497 - $175,951	1,938 Added 4.62%	43,895 $3.54 Million
Q4 2018 Jan 17, 2019	SELL	$77.85 - $96.01 $123,859 - $152,751	-1,591 Reduced 3.65%	41,957 $3.87 Million
Q3 2018 Oct 25, 2018	BUY	$88.91 - $98.84 $14,847 - $16,506	167 Added 0.38%	43,548 $4.12 Million
Q2 2018 Jul 11, 2018	SELL	$89.78 - $106.23 $181,984 - $215,328	-2,027 Reduced 4.46%	43,381 $4.02 Million
Q1 2018 Apr 20, 2018	BUY	$92.01 - $123.21 $501,454 - $671,494	5,450 Added 13.64%	45,408 $4.3 Million
Q4 2017 Feb 05, 2018	SELL	$89.56 - $98.21 $1.13 Million - $1.24 Million	-12,613 Reduced 23.99%	39,958 $3.86 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $3.67 Million - $4.69 Million	52,571	52,571 $4.67 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thomasville National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Thomasville National Bank with notifications on news.

Account

Thomasville National Bank Abb Vie Inc. Transaction History